- Report
- August 2022
- 120 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- August 2022
- 117 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- November 2021
- 102 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- November 2021
- 106 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- October 2021
- 110 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- October 2021
- 102 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- September 2021
- 115 Pages
Global
From €4028EUR$4,500USD£3,431GBP
- Report
- May 2021
- 120 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- May 2024
- 182 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- April 2024
- 180 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- November 2023
- 160 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- November 2023
- 160 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- October 2023
- 158 Pages
Europe
From €3222EUR$3,599USD£2,744GBP
- Report
- October 2023
- 140 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- October 2023
- 158 Pages
Latin America
From €3544EUR$3,959USD£3,019GBP
- Report
- September 2023
- 140 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- September 2023
- 140 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- September 2023
- 160 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- September 2023
- 140 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- April 2023
- 147 Pages
Global
From €4430EUR$4,949USD£3,774GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more